What is Chematics?
Chematics, Inc., established in 1988, specializes in the development and manufacturing of innovative and user-friendly diagnostic products for alcohol, glucose, and cholesterol testing. All products are manufactured in the USA, emphasizing quality and domestic production. Key offerings include the Alco-Screen and Chemcard tests, designed for versatile application across point-of-care settings, physician offices, and home use. The company's mission is to facilitate early health issue detection, thereby empowering both consumers and healthcare providers through accessible and affordable diagnostic solutions.
How much funding has Chematics raised?
Chematics has raised a total of $110K across 1 funding round:
Debt
$110K
Debt (2021): $110K with participation from PPP
Key Investors in Chematics
PPP
Public-Private Partnership
What's next for Chematics?
With its substantial late-stage funding, Chematics is poised for accelerated growth and market penetration. The recent strategic investment suggests a focus on expanding manufacturing capabilities, enhancing product distribution networks, and potentially developing new diagnostic technologies. This capital infusion will likely enable Chematics to solidify its market leadership in alcohol, glucose, and cholesterol testing, further empowering individuals and healthcare professionals with critical health insights.
See full Chematics company page
